Tim Bright

ORCID: 0000-0003-3700-5262
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Esophageal and GI Pathology
  • Esophageal Cancer Research and Treatment
  • Gastroesophageal reflux and treatments
  • Gastric Cancer Management and Outcomes
  • Helicobacter pylori-related gastroenterology studies
  • Eosinophilic Esophagitis
  • Dysphagia Assessment and Management
  • Congenital Diaphragmatic Hernia Studies
  • Gastrointestinal Tumor Research and Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Gastrointestinal disorders and treatments
  • Hernia repair and management
  • MicroRNA in disease regulation
  • Colorectal Cancer Screening and Detection
  • Circular RNAs in diseases
  • Extracellular vesicles in disease
  • Venous Thromboembolism Diagnosis and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Tracheal and airway disorders
  • Classical Philosophy and Thought
  • Lung Cancer Treatments and Mutations
  • Pancreatic and Hepatic Oncology Research
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Enhanced Recovery After Surgery
  • Potassium and Related Disorders

Flinders University
2015-2025

Flinders Medical Centre
2016-2025

Queen Elizabeth Hospital Birmingham
2022

University of Birmingham
2022

SUNY Upstate Medical University
2021

A.T. Still University
2020

University of King's College
2020

University of Cambridge
2020

Diversitech (United States)
2020

Royal Adelaide Hospital
2006-2016

David S. Liu Margaret M Lee Katheryn Hall David I. Watson Lorenzo Ferri and 95 more Jimmy Bok Yan So Claire L. Donohoe Michael Michael Niall C. Tebbutt Darren Wong Cuong Duong Tim Bright Ahmad Aly Sonia Gill Chao Cheng Su Kah Goh Matthew Read James Tan Sean R. Stevens Enoch Wong Geraldine Ooi Yick Ho Lam Eunice Lee David Williams Louise Jackett Chun Chan Garett Smith David L. Chan Neil D. Merrett Sivakumar Gananadha Harsh Kanhere Lauren R. Kennedy-Metz B. Mark Smithers Janine Thomas Michael Bozin Lynn Chong Krinal Mori Mary Ann Johnson Sarah A. Martin Val Usatoff Rod Jacobs Yahya Al-Habbal Chon Hann Liew Felicia C. Huynh Robert Bohmer Girish Pande Jurstine Daruwalla Mo Ballal Deanna Lee Rukshan Ranjan Andrew D MacCormick James M. Wilkins Sharon Pattison Nicholas Evennett James M. Wilkins Jason Robertson Mi PANG Alexandra Gordon Simon Bann Yu Kai Lim Inian Samarasam Ramesh Gurunathan Jonathan Yeung Frances Allison Aya Siblini Ewen A. Griffiths Alexander W. Phillips Pooja Prasad Sheraz Markar Swathikan Chidambaram David Chan Thomas Murphy John Reynolds Magnus Nilsson Fredrik Klevebro Guillaume Piessen Justine Lerooy Bas P. L. Wijnhoven Charlène van der Zijden Richard van Hillegersberg Lianne Triemstra Jelle P. Ruurda Mark I. van Berge Henegouwen Suzanne S. Gisbertz Pietro Maria Lombardi Amy C. Edmondson Joe Wei Aldenb Lorenzo Sam Alhayo Aaditya Narendra Aadil Rahim Rosemary Ho Jeremy Granger Steven Tran Michalis Koullouros Alain Nguyen Christina McVeay Siang Wei Gan Eve Hopping Iain Thomson

Abstract Background Many patients with locally advanced gastro-oesophageal cancers are unable to complete adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy, raising questions about its therapeutic utility. The aim of this study was examine whether pathological response neoadjuvant FLOT can guide use. Methods Patients non-metastatic adenocarcinoma who received underwent surgery from 1 January 2017 2022 43 hospitals across 12 countries were analysed....

10.1093/bjs/znaf056 article EN British journal of surgery 2025-03-28

Abstract Background Preoperative immunonutrition has been proposed to reduce the duration of hospital stay and infective complications following major elective surgery in patients with gastrointestinal malignancy. A multicentre 2 × factorial RCT was conducted determine impact preoperative postoperative versus standard nutrition oesophageal cancer. Methods Patients were randomized before oesophagectomy (IMPACT®) isocaloric/isonitrogenous nutrition, then further after operation nutrition....

10.1002/bjs.10923 article EN British journal of surgery 2018-07-12

In Brief Objective: To determine the efficacy of endoscopic argon plasma coagulation (APC) for ablation Barrett esophagus. Summary Background Data: APC has been used to ablate However, long-term outcome this treatment is unknown. This study reports 5-year results from a randomized trial versus surveillance esophagus in patients who had undergone fundoplication gastroesophageal reflux. Methods: Fifty-eight with were undergo either using or ongoing surveillance. At mean 68 months after...

10.1097/sla.0b013e318133fa85 article EN Annals of Surgery 2007-12-01

<b>Background and study aim:</b> Argon plasma coagulation (APC) has been used to ablate dysplastic nondysplastic Barrett's esophagus. We determined the longer-term efficacy of APC ablation within two randomized controlled trials versus surveillance for esophagus in patients whom gastroesophageal reflux was by either surgery or proton pump inhibitors. <b>Patients methods:</b> 129 (surgical trial 70, medical 59) with (nondysplastic low grade dysplasia) were randomly allocated using continuing...

10.1055/s-0033-1344584 article EN Endoscopy 2013-09-09

Objective: To evaluate late outcomes from a randomized trial of division versus no short gastric vessels during laparoscopic Nissen fundoplication at up to 20 years follow-up. Background: is an established procedure for the treatment gastroesophageal reflux disease. Controversy about whether side effects such as dysphagia could be reduced by led establishment in 1994. Early results showed equivalent control and dysphagia, but more bloating after vessel division. Methods: A total 102 patients...

10.1097/sla.0000000000002648 article EN Annals of Surgery 2018-01-05

BACKGROUNDCirculating microRNAs (miRNAs) are potential biomarkers for many diseases.However, they can originate from non-disease specific sources, such as blood cells, and compromise the investigations miRNA biomarkers.While small extracellular vesicles (sEVs) have been suggested to provide a purer source of circulating miRNAs discovery, most suitable sample sEV biomarker studies has not defined. AIMTo compare profiles between matched serum plasma preparations determine their suitability...

10.3748/wjg.v26.i20.2570 article EN cc-by-nc World Journal of Gastroenterology 2020-05-28

This Delphi exercise aimed to gather consensus surrounding risk factors, diagnosis, and management of chyle leaks after esophagectomy develop recommendations for clinical practice.Chyle following malignancy are uncommon. Although they associated with increased morbidity mortality, diagnosis these patients remain controversial a challenge globally.This was modified delivered clinicians across the oesophagogastric anastomosis collaborative. A 5-staged iterative process used on practice,...

10.1097/as9.0000000000000192 article EN cc-by-nc-nd Annals of Surgery Open 2022-08-29

Abstract Aim This study assessed the responsiveness and convergent validity of two preference-based measures; newly developed cancer-specific EORTC Quality Life Utility Measure-Core 10 dimensions (QLU-C10D) relative to generic three-level version EuroQol 5 (EQ-5D-3L) in evaluating short-term health related quality life (HRQoL) outcomes after esophagectomy. Methods Participants were enrolled a multicentre randomised controlled trial determine impact preoperative postoperative immunonutrition...

10.1186/s12955-021-01867-w article EN cc-by Health and Quality of Life Outcomes 2021-10-02

Abstract Background To standardize management of upper gastrointestinal ( GI ) cancer in S outh A ustralia, a statewide video linked multidisciplinary team MDT meeting was established late 2009. Although s are recognized as standard care, it is important to audit their impact. Methods retrospective outcomes and recommendations for patients reviewed by the between 1 J anuary 2010 31 D ecember 2011 undertaken. The proportion with new malignancies within 2 weeks diagnosis were determined....

10.1111/ans.12869 article EN ANZ Journal of Surgery 2014-10-07

At a national level, understanding preventable mortality after oesophago-gastric cancer surgery can direct quality-improvement efforts. Accordingly, utilizing the Australian and New Zealand Audit of Surgical Mortality (ANZASM), we aimed to: (1) determine causes death following resections in Australia, (2) quantify proportion potentially deaths, (3) identify clinical management issues contributing to mortality.All in-hospital mortalities from 1 January 2010 31 December 2020 were analysed...

10.1245/s10434-023-13571-8 article EN cc-by Annals of Surgical Oncology 2023-05-08

Background Volume–outcome relationships for mortality following oesophagectomy have been demonstrated in Europe and the USA, but not Australia or New Zealand. We determined whether higher volume hospitals achieve better outcomes Methods Administrative data contributing to Health Roundtable were analysed. Hospitals performing cancer from July 2008 June 2015 grouped according mean annual caseload: low (1–5), medium (6–11) high (12+) volume. Univariate multivariable analyses impact of on 30‐day...

10.1111/ans.15058 article EN ANZ Journal of Surgery 2019-03-11

Abstract Background With proton pump inhibitors and current sophisticated endoscopic techniques, the number of patients requiring surgical intervention for upper gastrointestinal bleeding has decreased considerably while trans‐arterial embolization is being used more often. There are few direct comparisons between effectiveness surgery embolization. Methods A retrospective study from two ustralian teaching hospitals who had or ( n = 103) severe haemorrhage 2004 2012 was carried out. Patient...

10.1111/ans.12588 article EN ANZ Journal of Surgery 2014-04-03
Coming Soon ...